Can governments tax their way to better health?

Governments around the world are turning to taxes on tobacco, alcohol, sugary drinks, and nicotine products as both a public health tool and a growing source of revenue at a time of mounting fiscal pressure. The shift comes as policymakers confront the enormous economic burden of chronic disease. According to the World Health Organization (WHO), noncommunicable, or chronic diseases such as cancer, diabetes, and cardiovascular disease kill roughly 43 million people annually, accounting for the vast majority of non-pandemic-related deaths worldwide.

Public health officials argue that taxation remains one of the most effective ways to reduce consumption of products linked to preventable illness while also generating revenue for strained healthcare systems. Yet the debate is becoming more complicated as vaping devices, nicotine pouches, and ultra-processed foods expand faster than many national tax systems can adapt. Governments now face a difficult balancing act between discouraging harmful consumption, responding to evolving research around harm reduction, and limiting smuggling networks that undermine both public health goals and state revenue collection.

A public health tool with expanding reach

For decades, cigarette taxes served as one of the clearest examples of taxation being used to influence public behavior. Raising prices reduced smoking rates, particularly among younger consumers, while also generating substantial government revenue.

That model has now expanded into a much broader category of “health taxes” targeting products associated with preventable disease. In 2026, the WHO urged governments to increase taxes not only on tobacco, but also on alcohol and sugary drinks as part of a wider strategy to combat rising obesity, diabetes, and cardiovascular disease rates worldwide.

The push reflects mounting evidence linking consumption patterns to long-term healthcare costs. A 2025 study published in The Lancet Public Health found that sugar-sweetened beverage taxes were associated with measurable declines in purchases of high-sugar drinks across multiple countries. Separate research from the University of California, Berkeley examining soda taxes in several U.S. cities found sustained reductions in sugary drink consumption alongside increased water purchases and improved health indicators.

The fiscal incentive is equally significant. Former IMF officials and public finance experts argue that health taxes are attracting renewed attention as governments confront rising healthcare costs and mounting fiscal pressure. In a 2025 analysis discussed by the WHO, tax experts argued that excise taxes on products linked to preventable disease can serve a dual function by generating revenue,  while also discouraging harmful consumption.

The rise of harm reduction

The emergence of vaping devices, nicotine pouches, and heated tobacco products has complicated the traditional public health tax model. Policymakers now face a difficult question about whether all nicotine products should be taxed equally, or whether lower-risk alternatives should receive preferential treatment to encourage smokers to move away from combustible cigarettes.

The debate matters because of the extraordinary health burden linked to smoking itself. According to the R Street Institute, a U.S.-based public policy research organization, cigarette smoke contains more than 7,000 chemicals, at least 70 of which are known carcinogens.

Several recent studies argue that risk-proportionate taxation may produce better public health outcomes than uniform taxation across all nicotine products. Public Health England’s landmark independent review concluded that e-cigarettes are approximately 95 percent less harmful than combustible cigarettes. The U.S. Food and Drug Administration has also signaled that different nicotine products carry different levels of health risk. In January 2025, the FDA authorized 20 ZYN nicotine pouch products after determining they were appropriate for public health protection.

Supporters of harm-reduction tax models argue that lower taxes on vaping products or nicotine pouches can create financial incentives for smokers to transition away from cigarettes. Sweden is frequently cited as the clearest real-world example. According to the R Street Institute, through widespread adoption of nicotine pouches and snus, an oral tobacco product placed under the upper lip, Sweden has reduced its daily smoking rate to just 5.3 percent, the lowest in Europe. Lung cancer death rates among Swedish men are estimated to be roughly 61 percent lower than the European average, while researchers estimate snus saves approximately 3,000 Swedish lives annually.

Tax sensitivity also appears to vary significantly between products. A Global State of Tobacco Harm Reduction (GSTHR) briefing paper notes that a 1 percent increase in cigarette prices typically reduces consumption by only 0.4 to 0.7 percent. For vaping products, the same price increase can reduce demand by between 0.8 and 2.2 percent, suggesting consumers may be more responsive to vape taxation than cigarette taxation.

That creates a complicated policy dilemma. Excessively high taxes on vaping products may reduce youth uptake, but critics argue they can also discourage adult smokers from switching away from combustible tobacco.

A fragmented global tax landscape

The rapid expansion of alternative nicotine products has exposed how outdated many national tax systems have become. Governments are attempting to regulate markets that barely existed fifteen years ago, often while relying on tax structures originally designed for conventional cigarettes.

As of 2023, at least 54 countries had implemented excise taxes on vaping products, according to the GSTHR briefing paper. The scale of those taxes varied dramatically, ranging from zero percent in Croatia to 88 percent in Belarus. Heated tobacco products faced similarly inconsistent treatment. By 2023, 66 countries had taxes on heated tobacco products, with tax burdens ranging from 2 percent in Andorra to 79 percent in Palestine.

That fragmentation creates opportunities for smuggling, tax arbitrage, and illicit markets. Research published in the International Journal of Environmental Research and Public Health found that large tax disparities between neighboring countries continue fueling cross-border cigarette smuggling networks that weaken both public health policy and government revenue collection.

The same challenge is now emerging with vaping products and nicotine pouches, which are often sold through fragmented online and informal retail networks that regulators struggle to monitor effectively.

Critics of health taxes also argue that these policies can place disproportionate burdens on lower-income households because consumption taxes consume a larger share of poorer consumers’ income. Supporters counter that lower-income populations also experience disproportionately high rates of smoking-related illness, obesity, and diabetes, meaning they may benefit the most from reduced consumption.

The broader debate ultimately reflects a larger shift in how governments view taxation itself. Health taxes are no longer simply a mechanism for raising revenue. They are becoming a policy tool through which states attempt to reduce preventable disease, manage long-term healthcare costs, and influence consumption patterns.